Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis.

Ferreras JA, Ryu JS, Di Lello F, Tan DS, Quadri LE.

Nat Chem Biol. 2005 Jun;1(1):29-32. Epub 2005 May 24.

PMID:
16407990
2.

Targeting iron acquisition by Mycobacterium tuberculosis.

Monfeli RR, Beeson C.

Infect Disord Drug Targets. 2007 Sep;7(3):213-20. Review.

PMID:
17897057
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.

Oliveira JS, de Sousa EH, de Souza ON, Moreira IS, Santos DS, Basso LA.

Curr Pharm Des. 2006;12(19):2409-24. Review.

PMID:
16842188
5.

Strategic paradigm shifts in the antimicrobial drug discovery process of the 21st century.

Quadri LE.

Infect Disord Drug Targets. 2007 Sep;7(3):230-7. Review.

PMID:
17897059
6.

Control of iron metabolism in Mycobacterium tuberculosis.

Rodriguez GM.

Trends Microbiol. 2006 Jul;14(7):320-7. Epub 2006 Jun 6. Review.

PMID:
16759864
7.

Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis.

Tonge PJ, Kisker C, Slayden RA.

Curr Top Med Chem. 2007;7(5):489-98. Review.

PMID:
17346194
8.

Iron and siderophores in fungal-host interactions.

Johnson L.

Mycol Res. 2008 Feb;112(Pt 2):170-83. doi: 10.1016/j.mycres.2007.11.012. Epub 2007 Dec 14. Review.

PMID:
18280720
9.

Iron Acquisition Pathways as Targets for Antitubercular Drugs.

Meneghetti F, Villa S, Gelain A, Barlocco D, Chiarelli LR, Pasca MR, Costantino L.

Curr Med Chem. 2016;23(35):4009-4026. Review.

PMID:
27281295
10.

Comparative genomic insights into the biosynthesis and regulation of mycobacterial siderophores.

Li W, He J, Xie L, Chen T, Xie J.

Cell Physiol Biochem. 2013;31(1):1-13. doi: 10.1159/000343343. Epub 2013 Jan 14. Review.

11.

5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.

Velaparthi S, Brunsteiner M, Uddin R, Wan B, Franzblau SG, Petukhov PA.

J Med Chem. 2008 Apr 10;51(7):1999-2002. doi: 10.1021/jm701372r. Epub 2008 Mar 13. Review.

PMID:
18335974
12.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.

13.

Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.

Van Calenbergh S.

Verh K Acad Geneeskd Belg. 2006;68(4):223-48. Review.

PMID:
17214439
14.

Purine metabolism in Mycobacterium tuberculosis as a target for drug development.

Parker WB, Long MC.

Curr Pharm Des. 2007;13(6):599-608. Review.

PMID:
17346177
15.

Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis.

de Souza MV, Ferreira Mde L, Pinheiro AC, Saraiva MF, de Almeida MV, Valle MS.

ScientificWorldJournal. 2008 Jul 31;8:720-51. doi: 10.1100/tsw.2008.99. Review.

16.

Studies and syntheses of siderophores, microbial iron chelators, and analogs as potential drug delivery agents.

Roosenberg JM 2nd, Lin YM, Lu Y, Miller MJ.

Curr Med Chem. 2000 Feb;7(2):159-97. Review.

PMID:
10637361
17.

Yersiniae and iron. A study in host-parasite relationships.

Robins-Browne RM, Prpic JK, Stuart SJ.

Contrib Microbiol Immunol. 1987;9:254-8. Review.

PMID:
3311635
18.

Iron, mycobacteria and tuberculosis.

Ratledge C.

Tuberculosis (Edinb). 2004;84(1-2):110-30. Review.

PMID:
14670352
19.
20.

Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents.

Miller MJ, Zhu H, Xu Y, Wu C, Walz AJ, Vergne A, Roosenberg JM, Moraski G, Minnick AA, McKee-Dolence J, Hu J, Fennell K, Kurt Dolence E, Dong L, Franzblau S, Malouin F, Möllmann U.

Biometals. 2009 Feb;22(1):61-75. doi: 10.1007/s10534-008-9185-0. Epub 2009 Jan 7. Review.

Supplemental Content

Support Center